Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Gillheeney Gary S.
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Gillheeney Gary S.
Organogenesis | 144: Notice of proposed sale of securities pursuant to Rule 144
Organogenesis | 4: Statement of changes in beneficial ownership of securities-10% Owner GN 2016 Family Trust u/a/d August 12, 2016
Organogenesis | 4: Statement of changes in beneficial ownership of securities-10% Owner GN 2016 Family Trust u/a/d August 12, 2016
Organogenesis | 8-K: Current report
Organogenesis | D: Filing D
Organogenesis | 8-K: Current report
Organogenesis | SC 13D: Statement of acquisition of beneficial ownership by individuals-Thompson Dean(18.0%),David Burgstahler(17.6%), etc.
Organogenesis | 3: Initial statement of beneficial ownership of securities-10% Owner Avista Capital Managing Member VI, LLC
Organogenesis | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alan A. Ades(17.8%),Albert Erani(14.3%), etc.
Organogenesis | 3: Initial statement of beneficial ownership of securities-Director Lustig Garrett
Organogenesis | 4: Statement of changes in beneficial ownership of securities-10% Owner ERANI ALBERT
Organogenesis | 4: Statement of changes in beneficial ownership of securities-10% Owner ERANI ALBERT
Organogenesis | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Soleus Capital Master Fund, L.P.(8.9%),Soleus Capital, LLC(8.9%), etc.
Organogenesis | 8-K: Current report
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
Organogenesis | 10-Q: Q3 2024 Earnings Report
Organogenesis | EFFECT: Others
Organogenesis | UPLOAD: Others
No Data